APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fibrinogen

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Selected research

Industry Growth & Trends

Global Fibrinogen Industry Growth and Trends Forecast to 2032

27 December 2025102 pages

Choose your research edition.

Industry ResearchFibrinogen Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Fibrinogen Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Fibrinogen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fibrinogen Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Fibrinogen Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Fibrinogen market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Fibrinogen market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fibrinogen market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fibrinogen.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Fibrinogen market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Fibrinogen Market by Company

CSL Behring

LFB Group

Shanghai RAAS Blood Products

Jiangxi Boya Bio-Pharmaceutical

Hualan Biological Engineering

Harbin Pacific Biopharmaceutical

GREEN CROSS

Shanghai XinXing Medical

Taibang Biologic

Octapharma

Fibrinogen Segment by Type

Human Fibrinogen

Animal Fibrinogen

Fibrinogen Segment by Application

Congenital Fibrinogen Deficiency

Surgical Procedures

Others

Fibrinogen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrinogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fibrinogen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrinogen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fibrinogen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Fibrinogen Table 2. Major Company of Animal Fibrinogen Table 3. Global Fibrinogen Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Fibrinogen Sales by Type (2021-2026) & (Kg) Table 5. Global Fibrinogen Sales Market Share in Volume by Type (2021-2026) Table 6. Global Fibrinogen Sales by Type (2021-2026) & (US$ Million) Table 7. Global Fibrinogen Sales Market Share in Value by Type (2021-2026) Table 8. Global Fibrinogen Price by Type (2021-2026) & (US$/g) Table 9. Global Fibrinogen Sales by Type (2027-2032) & (Kg) Table 10. Global Fibrinogen Sales Market Share in Volume by Type (2027-2032) Table 11. Global Fibrinogen Sales by Type (2027-2032) & (US$ Million) Table 12. Global Fibrinogen Sales Market Share in Value by Type (2027-2032) Table 13. Global Fibrinogen Price by Type (2027-2032) & (US$/g) Table 14. North America Fibrinogen Sales by Type (2021-2026) & (Kg) Table 15. North America Fibrinogen Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Fibrinogen Sales by Type (2021-2026) & (Kg) Table 17. Europe Fibrinogen Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Fibrinogen Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Fibrinogen Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Fibrinogen Sales by Type (2021-2026) & (Kg) Table 21. Latin America Fibrinogen Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Fibrinogen Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Fibrinogen Sales by Type (2021-2026) & (US$ Million) Table 24. Fibrinogen Industry Trends Table 25. Fibrinogen Industry Drivers Table 26. Fibrinogen Industry Opportunities and Challenges Table 27. Fibrinogen Industry Restraints Table 28. Global Fibrinogen Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Fibrinogen Revenue Market Share by Company (2021-2026) Table 30. Global Fibrinogen Sales by Company (2021-2026) & (Kg) Table 31. Global Fibrinogen Sales Share by Company (2021-2026) Table 32. Global Fibrinogen Market Price by Company (2021-2026) & (US$/g) Table 33. Global Fibrinogen Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Fibrinogen Major Company Production Sites and Headquarters Table 35. Global Fibrinogen Company, Product Type & Application Table 36. Global Fibrinogen Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Fibrinogen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Fibrinogen Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Fibrinogen Sales by Region (2021-2026) & (Kg) Table 41. Global Fibrinogen Sales Market Share in Volume by Region (2021-2026) Table 42. Global Fibrinogen Sales by Region (2021-2026) & (US$ Million) Table 43. Global Fibrinogen Sales Market Share in Value by Region (2021-2026) Table 44. Global Fibrinogen Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Fibrinogen Sales by Region (2027-2032) & (Kg) Table 46. Global Fibrinogen Sales Market Share in Volume by Region (2027-2032) Table 47. Global Fibrinogen Sales by Region (2027-2032) & (US$ Million) Table 48. Global Fibrinogen Sales Market Share in Value by Region (2027-2032) Table 49. Global Fibrinogen Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Fibrinogen Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Fibrinogen Sales by Application (2021-2026) & (Kg) Table 52. Global Fibrinogen Sales Market Share in Volume by Application (2021-2026) Table 53. Global Fibrinogen Sales by Application (2021-2026) & (US$ Million) Table 54. Global Fibrinogen Sales Market Share in Value by Application (2021-2026) Table 55. Global Fibrinogen Price by Application (2021-2026) & (US$/g) Table 56. Global Fibrinogen Sales by Application (2027-2032) & (Kg) Table 57. Global Fibrinogen Sales Market Share in Volume by Application (2027-2032) Table 58. Global Fibrinogen Sales by Application (2027-2032) & (US$ Million) Table 59. Global Fibrinogen Sales Market Share in Value by Application (2027-2032) Table 60. Global Fibrinogen Price by Application (2027-2032) & (US$/g) Table 61. North America Fibrinogen Sales by Application (2021-2026) & (Kg) Table 62. North America Fibrinogen Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Fibrinogen Sales by Application (2021-2026) & (Kg) Table 64. Europe Fibrinogen Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Fibrinogen Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Fibrinogen Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Fibrinogen Sales by Application (2021-2026) & (Kg) Table 68. Latin America Fibrinogen Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Fibrinogen Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Fibrinogen Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Behring Company Information Table 72. CSL Behring Business Overview Table 73. CSL Behring Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. CSL Behring Fibrinogen Product Portfolio Table 75. CSL Behring Recent Development Table 76. LFB Group Company Information Table 77. LFB Group Business Overview Table 78. LFB Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. LFB Group Fibrinogen Product Portfolio Table 80. LFB Group Recent Development Table 81. Shanghai RAAS Blood Products Company Information Table 82. Shanghai RAAS Blood Products Business Overview Table 83. Shanghai RAAS Blood Products Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Shanghai RAAS Blood Products Fibrinogen Product Portfolio Table 85. Shanghai RAAS Blood Products Recent Development Table 86. Jiangxi Boya Bio-Pharmaceutical Company Information Table 87. Jiangxi Boya Bio-Pharmaceutical Business Overview Table 88. Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product Portfolio Table 90. Jiangxi Boya Bio-Pharmaceutical Recent Development Table 91. Hualan Biological Engineering Company Information Table 92. Hualan Biological Engineering Business Overview Table 93. Hualan Biological Engineering Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. Hualan Biological Engineering Fibrinogen Product Portfolio Table 95. Hualan Biological Engineering Recent Development Table 96. Harbin Pacific Biopharmaceutical Company Information Table 97. Harbin Pacific Biopharmaceutical Business Overview Table 98. Harbin Pacific Biopharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. Harbin Pacific Biopharmaceutical Fibrinogen Product Portfolio Table 100. Harbin Pacific Biopharmaceutical Recent Development Table 101. GREEN CROSS Company Information Table 102. GREEN CROSS Business Overview Table 103. GREEN CROSS Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. GREEN CROSS Fibrinogen Product Portfolio Table 105. GREEN CROSS Recent Development Table 106. Shanghai XinXing Medical Company Information Table 107. Shanghai XinXing Medical Business Overview Table 108. Shanghai XinXing Medical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Shanghai XinXing Medical Fibrinogen Product Portfolio Table 110. Shanghai XinXing Medical Recent Development Table 111. Taibang Biologic Company Information Table 112. Taibang Biologic Business Overview Table 113. Taibang Biologic Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 114. Taibang Biologic Fibrinogen Product Portfolio Table 115. Taibang Biologic Recent Development Table 116. Octapharma Company Information Table 117. Octapharma Business Overview Table 118. Octapharma Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 119. Octapharma Fibrinogen Product Portfolio Table 120. Octapharma Recent Development Table 121. North America Fibrinogen Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. North America Fibrinogen Sales by Country (2021-2026) & (Kg) Table 123. North America Fibrinogen Sales Market Share by Country (2021-2026) Table 124. North America Fibrinogen Sales Forecast by Country (2027-2032) & (Kg) Table 125. North America Fibrinogen Sales Market Share Forecast by Country (2027-2032) Table 126. North America Fibrinogen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Fibrinogen Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Fibrinogen Market Share by Country (2021-2026) Table 129. North America Fibrinogen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Fibrinogen Market Share Forecast by Country (2027-2032) Table 131. Europe Fibrinogen Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Europe Fibrinogen Sales by Country (2021-2026) & (Kg) Table 133. Europe Fibrinogen Sales Market Share by Country (2021-2026) Table 134. Europe Fibrinogen Sales Forecast by Country (2027-2032) & (Kg) Table 135. Europe Fibrinogen Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Fibrinogen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Fibrinogen Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Fibrinogen Market Share by Country (2021-2026) Table 139. Europe Fibrinogen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Fibrinogen Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Fibrinogen Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Fibrinogen Sales by Country (2021-2026) & (Kg) Table 143. Asia-Pacific Fibrinogen Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Fibrinogen Sales Forecast by Country (2027-2032) & (Kg) Table 145. Asia-Pacific Fibrinogen Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Fibrinogen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Fibrinogen Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Fibrinogen Market Share by Country (2021-2026) Table 149. Asia-Pacific Fibrinogen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Fibrinogen Market Share Forecast by Country (2027-2032) Table 151. Latin America Fibrinogen Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 152. Latin America Fibrinogen Sales by Country (2021-2026) & (Kg) Table 153. Latin America Fibrinogen Sales Market Share by Country (2021-2026) Table 154. Latin America Fibrinogen Sales Forecast by Country (2027-2032) & (Kg) Table 155. Latin America Fibrinogen Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Fibrinogen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Fibrinogen Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Fibrinogen Market Share by Country (2021-2026) Table 159. Latin America Fibrinogen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Fibrinogen Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Fibrinogen Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Fibrinogen Sales by Country (2021-2026) & (Kg) Table 163. Middle East and Africa Fibrinogen Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Fibrinogen Sales Forecast by Country (2027-2032) & (Kg) Table 165. Middle East and Africa Fibrinogen Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Fibrinogen Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Fibrinogen Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Fibrinogen Market Share by Country (2021-2026) Table 169. Middle East and Africa Fibrinogen Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Fibrinogen Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Fibrinogen Distributors List Table 174. Fibrinogen Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Fibrinogen Image Figure 2. Global Fibrinogen Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fibrinogen Market Size (2021-2032) & (US$ Million) Figure 4. Global Fibrinogen Sales (2021-2032) & (Kg) Figure 5. Human Fibrinogen Image Figure 6. Global Human Fibrinogen Sales YoY Growth (2021-2032) & (Kg) Figure 7. Animal Fibrinogen Image Figure 8. Global Animal Fibrinogen Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Fibrinogen Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Fibrinogen Market Share by Type 2025 VS 2032 Figure 11. North America Fibrinogen Sales Market Share in Volume by Type in 2025 Figure 12. North America Fibrinogen Sales Market Share in Value by Type in 2025 Figure 13. Europe Fibrinogen Sales Market Share in Volume by Type in 2025 Figure 14. Europe Fibrinogen Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Fibrinogen Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Fibrinogen Sales Market Share in Value by Type in 2025 Figure 17. Latin America Fibrinogen Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Fibrinogen Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Fibrinogen Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Fibrinogen Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Fibrinogen Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Congenital Fibrinogen Deficiency Image Figure 24. Global Congenital Fibrinogen Deficiency Sales YoY Growth (2021-2032) & (Kg) Figure 25. Surgical Procedures Image Figure 26. Global Surgical Procedures Sales YoY Growth (2021-2032) & (Kg) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 29. Global Fibrinogen Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Fibrinogen Market Share by Application 2025 VS 2032 Figure 31. North America Fibrinogen Sales Market Share in Volume by Application in 2025 Figure 32. North America Fibrinogen Sales Market Share in Value by Application in 2025 Figure 33. Europe Fibrinogen Sales Market Share in Volume by Application in 2025 Figure 34. Europe Fibrinogen Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Fibrinogen Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Fibrinogen Sales Market Share in Value by Application in 2025 Figure 37. Latin America Fibrinogen Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Fibrinogen Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Fibrinogen Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Fibrinogen Sales Market Share in Value by Application in 2025 Figure 41. North America Fibrinogen Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 42. North America Fibrinogen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Fibrinogen Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Fibrinogen Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. Europe Fibrinogen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Fibrinogen Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Fibrinogen Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Asia-Pacific Fibrinogen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Fibrinogen Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Fibrinogen Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Latin America Fibrinogen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Fibrinogen Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Fibrinogen Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Middle East and Africa Fibrinogen Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Fibrinogen Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Fibrinogen Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Fibrinogen Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Human Fibrinogen
  • Animal Fibrinogen
Applications
  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others
Companies covered
  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • Jiangxi Boya Bio-Pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • GREEN CROSS
  • Shanghai XinXing Medical
  • Taibang Biologic
  • Octapharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fibrinogen Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Fibrinogen Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Fibrinogen Market by Type
  6. 1.3.1 Human Fibrinogen
  7. 1.3.2 Animal Fibrinogen
  8. 1.4 Global Fibrinogen Market Size by Type
  9. 1.4.1 Global Fibrinogen Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Fibrinogen Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Fibrinogen Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Fibrinogen Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Fibrinogen Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Fibrinogen Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Fibrinogen Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Fibrinogen Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Fibrinogen Industry Trends
  2. 2.2 Fibrinogen Industry Drivers
  3. 2.3 Fibrinogen Industry Opportunities and Challenges
  4. 2.4 Fibrinogen Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Fibrinogen Revenue (2021-2026)
  2. 3.2 Global Top Players by Fibrinogen Sales (2021-2026)
  3. 3.3 Global Top Players by Fibrinogen Price (2021-2026)
  4. 3.4 Global Fibrinogen Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fibrinogen Major Company Production Sites & Headquarters
  6. 3.6 Global Fibrinogen Company, Product Type & Application
  7. 3.7 Global Fibrinogen Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fibrinogen Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fibrinogen Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fibrinogen Tier 1, Tier 2, and Tier 3
4 Fibrinogen Regional Status and Outlook
  1. 4.1 Global Fibrinogen Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Fibrinogen Historic Market Size by Region
  3. 4.2.1 Global Fibrinogen Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Fibrinogen Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Fibrinogen Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Fibrinogen Forecasted Market Size by Region
  7. 4.3.1 Global Fibrinogen Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Fibrinogen Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Fibrinogen Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fibrinogen by Application
  1. 5.1 Fibrinogen Market by Application
  2. 5.1.1 Congenital Fibrinogen Deficiency
  3. 5.1.2 Surgical Procedures
  4. 5.1.3 Others
  5. 5.2 Global Fibrinogen Market Size by Application
  6. 5.2.1 Global Fibrinogen Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Fibrinogen Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Fibrinogen Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Fibrinogen Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Fibrinogen Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Fibrinogen Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Fibrinogen Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Fibrinogen Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL Behring
  2. 6.1.1 CSL Behring Company Information
  3. 6.1.2 CSL Behring Business Overview
  4. 6.1.3 CSL Behring Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Behring Fibrinogen Product Portfolio
  6. 6.1.5 CSL Behring Recent Developments
  7. 6.2 LFB Group
  8. 6.2.1 LFB Group Company Information
  9. 6.2.2 LFB Group Business Overview
  10. 6.2.3 LFB Group Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 LFB Group Fibrinogen Product Portfolio
  12. 6.2.5 LFB Group Recent Developments
  13. 6.3 Shanghai RAAS Blood Products
  14. 6.3.1 Shanghai RAAS Blood Products Company Information
  15. 6.3.2 Shanghai RAAS Blood Products Business Overview
  16. 6.3.3 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai RAAS Blood Products Fibrinogen Product Portfolio
  18. 6.3.5 Shanghai RAAS Blood Products Recent Developments
  19. 6.4 Jiangxi Boya Bio-Pharmaceutical
  20. 6.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
  21. 6.4.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
  22. 6.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product Portfolio
  24. 6.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
  25. 6.5 Hualan Biological Engineering
  26. 6.5.1 Hualan Biological Engineering Company Information
  27. 6.5.2 Hualan Biological Engineering Business Overview
  28. 6.5.3 Hualan Biological Engineering Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hualan Biological Engineering Fibrinogen Product Portfolio
  30. 6.5.5 Hualan Biological Engineering Recent Developments
  31. 6.6 Harbin Pacific Biopharmaceutical
  32. 6.6.1 Harbin Pacific Biopharmaceutical Company Information
  33. 6.6.2 Harbin Pacific Biopharmaceutical Business Overview
  34. 6.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Product Portfolio
  36. 6.6.5 Harbin Pacific Biopharmaceutical Recent Developments
  37. 6.7 GREEN CROSS
  38. 6.7.1 GREEN CROSS Company Information
  39. 6.7.2 GREEN CROSS Business Overview
  40. 6.7.3 GREEN CROSS Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GREEN CROSS Fibrinogen Product Portfolio
  42. 6.7.5 GREEN CROSS Recent Developments
  43. 6.8 Shanghai XinXing Medical
  44. 6.8.1 Shanghai XinXing Medical Company Information
  45. 6.8.2 Shanghai XinXing Medical Business Overview
  46. 6.8.3 Shanghai XinXing Medical Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai XinXing Medical Fibrinogen Product Portfolio
  48. 6.8.5 Shanghai XinXing Medical Recent Developments
  49. 6.9 Taibang Biologic
  50. 6.9.1 Taibang Biologic Company Information
  51. 6.9.2 Taibang Biologic Business Overview
  52. 6.9.3 Taibang Biologic Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Taibang Biologic Fibrinogen Product Portfolio
  54. 6.9.5 Taibang Biologic Recent Developments
  55. 6.10 Octapharma
  56. 6.10.1 Octapharma Company Information
  57. 6.10.2 Octapharma Business Overview
  58. 6.10.3 Octapharma Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Octapharma Fibrinogen Product Portfolio
  60. 6.10.5 Octapharma Recent Developments
7 North America by Country
  1. 7.1 North America Fibrinogen Sales by Country
  2. 7.1.1 North America Fibrinogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Fibrinogen Sales by Country (2021-2026)
  4. 7.1.3 North America Fibrinogen Sales Forecast by Country (2027-2032)
  5. 7.2 North America Fibrinogen Market Size by Country
  6. 7.2.1 North America Fibrinogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Fibrinogen Market Size by Country (2021-2026)
  8. 7.2.3 North America Fibrinogen Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Fibrinogen Sales by Country
  2. 8.1.1 Europe Fibrinogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Fibrinogen Sales by Country (2021-2026)
  4. 8.1.3 Europe Fibrinogen Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Fibrinogen Market Size by Country
  6. 8.2.1 Europe Fibrinogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Fibrinogen Market Size by Country (2021-2026)
  8. 8.2.3 Europe Fibrinogen Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Fibrinogen Sales by Country
  2. 9.1.1 Asia-Pacific Fibrinogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Fibrinogen Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Fibrinogen Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Fibrinogen Market Size by Country
  6. 9.2.1 Asia-Pacific Fibrinogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Fibrinogen Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Fibrinogen Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Fibrinogen Sales by Country
  2. 10.1.1 South America Fibrinogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Fibrinogen Sales by Country (2021-2026)
  4. 10.1.3 South America Fibrinogen Sales Forecast by Country (2027-2032)
  5. 10.2 South America Fibrinogen Market Size by Country
  6. 10.2.1 South America Fibrinogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Fibrinogen Market Size by Country (2021-2026)
  8. 10.2.3 South America Fibrinogen Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Fibrinogen Sales by Country
  2. 11.1.1 Middle East and Africa Fibrinogen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Fibrinogen Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Fibrinogen Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Fibrinogen Market Size by Country
  6. 11.2.1 Middle East and Africa Fibrinogen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Fibrinogen Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Fibrinogen Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Fibrinogen Value Chain Analysis
  2. 12.1.1 Fibrinogen Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Fibrinogen Production Mode & Process
  7. 12.2 Fibrinogen Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Fibrinogen Distributors
  10. 12.2.3 Fibrinogen Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst